Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of remimazolam, propofol, and inhalational agents on postoperative nausea and vomiting
jRCT1041210079Completed
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam and propofol in general anesthesia (3 arms), sponsored by Hamamatsu University School of Medicine. Primary endpoint: incidence of postoperative nausea and vomiting. Started Oct 2021; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on jRCT1041210079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041210079.